PT1280522E - Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica - Google Patents

Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica

Info

Publication number
PT1280522E
PT1280522E PT01920625T PT01920625T PT1280522E PT 1280522 E PT1280522 E PT 1280522E PT 01920625 T PT01920625 T PT 01920625T PT 01920625 T PT01920625 T PT 01920625T PT 1280522 E PT1280522 E PT 1280522E
Authority
PT
Portugal
Prior art keywords
hypertensions
ethylic
eters
carboxyl
combination
Prior art date
Application number
PT01920625T
Other languages
English (en)
Inventor
Auerbach Bruce
Hitchcock Karen Diane
Ryan Michael
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT1280522E publication Critical patent/PT1280522E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT01920625T 2000-04-26 2001-03-22 Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica PT1280522E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19985500P 2000-04-26 2000-04-26
US24228000P 2000-10-20 2000-10-20

Publications (1)

Publication Number Publication Date
PT1280522E true PT1280522E (pt) 2005-02-28

Family

ID=26895229

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01920625T PT1280522E (pt) 2000-04-26 2001-03-22 Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica

Country Status (34)

Country Link
EP (1) EP1280522B1 (pt)
JP (1) JP2003531170A (pt)
KR (1) KR20020091245A (pt)
CN (1) CN1426299A (pt)
AP (1) AP2002002665A0 (pt)
AR (1) AR031104A1 (pt)
AT (1) ATE283691T1 (pt)
AU (1) AU2001247658A1 (pt)
BG (1) BG107264A (pt)
BR (1) BR0110234A (pt)
CA (1) CA2405559A1 (pt)
CZ (1) CZ20023459A3 (pt)
DE (1) DE60107559T2 (pt)
DO (1) DOP2001000150A (pt)
EA (1) EA005245B1 (pt)
EE (1) EE200200611A (pt)
ES (1) ES2231470T3 (pt)
HR (1) HRP20020936A2 (pt)
HU (1) HUP0300403A3 (pt)
IL (1) IL152474A0 (pt)
IS (1) IS6570A (pt)
MA (1) MA26894A1 (pt)
MX (1) MXPA02009662A (pt)
NO (1) NO20025135L (pt)
NZ (1) NZ521713A (pt)
OA (1) OA12252A (pt)
PA (1) PA8516001A1 (pt)
PE (1) PE20011308A1 (pt)
PL (1) PL357906A1 (pt)
PT (1) PT1280522E (pt)
SK (1) SK15132002A3 (pt)
SV (1) SV2002000367A (pt)
TN (1) TNSN01061A1 (pt)
WO (1) WO2001080847A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
BRPI0812597A2 (pt) * 2007-06-21 2015-02-18 Actimis Pharmaceuticals Inc Sal, composição farmacêutica, métodos para o tratamento, prevenção ou melhora de um ou mais sintomas de uma doença mediada por crth2, de uma doença relacionada com eosinófilo, de uma doença relacionada com basófilo, e de uma doença inflamatória, e, processo para a preparação do sal
DE102008026033B4 (de) * 2008-05-30 2017-08-24 Voith Patent Gmbh Antriebsstrang mit einer hydrodynamischen Maschine
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
WO2001080847A3 (en) 2002-07-18
IS6570A (is) 2002-09-27
PA8516001A1 (es) 2002-09-17
HRP20020936A2 (en) 2004-12-31
EP1280522A2 (en) 2003-02-05
TNSN01061A1 (en) 2005-11-10
AU2001247658A1 (en) 2001-11-07
IL152474A0 (en) 2003-05-29
BR0110234A (pt) 2003-03-05
DOP2001000150A (es) 2002-08-15
AP2002002665A0 (en) 2002-12-31
MXPA02009662A (es) 2003-03-10
PE20011308A1 (es) 2002-01-18
SK15132002A3 (sk) 2003-08-05
JP2003531170A (ja) 2003-10-21
NZ521713A (en) 2004-09-24
WO2001080847A2 (en) 2001-11-01
CZ20023459A3 (cs) 2003-05-14
EA005245B1 (ru) 2004-12-30
EP1280522B1 (en) 2004-12-01
OA12252A (en) 2006-05-11
AR031104A1 (es) 2003-09-10
NO20025135L (no) 2002-11-27
CA2405559A1 (en) 2001-11-01
BG107264A (en) 2003-07-31
SV2002000367A (es) 2002-08-26
NO20025135D0 (no) 2002-10-25
ES2231470T3 (es) 2005-05-16
DE60107559D1 (de) 2005-01-05
MA26894A1 (fr) 2004-12-20
HUP0300403A2 (hu) 2003-06-28
CN1426299A (zh) 2003-06-25
KR20020091245A (ko) 2002-12-05
DE60107559T2 (de) 2005-04-14
EE200200611A (et) 2004-06-15
HUP0300403A3 (en) 2005-03-29
ATE283691T1 (de) 2004-12-15
EA200200953A1 (ru) 2003-04-24
PL357906A1 (en) 2004-08-09

Similar Documents

Publication Publication Date Title
DE50112013D1 (de) Deodorantien und antiperspirantien
CY2013030I1 (el) Αναστρεψιμα απενεργοποιημενη οξινισμενη πλασμινη
DE60032747D1 (de) Annäherungssensor
NO20003967D0 (no) Farmasøytiske preparater
DE10085137T1 (de) Chirurgischer Sensor
DE60026031D1 (de) Insassensensor
ATE311915T1 (de) Medikamentenspender
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
DE60130288D1 (de) NOx Sensor
DE50102799D1 (de) Beleuchtungs- und anzeigevorrichtung
PT1189895E (pt) Derivados de tiazole e oxazole e sua utilizacao farmaceutica
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
DE50001455D1 (de) Blisterverpackung
DE60120009D1 (de) Zylinder und Positionsgeber
NO20022645L (no) Farmasöytisk superdisintegrerende stoff
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
PT1254133E (pt) Derivados de indol-3-ilo e a sua utilizacao como inibidores da integrina
NO20024806D0 (no) Apomorfinderivater samt anvendelse derav
NO20022606D0 (no) Farmasöytiske kombinasjoner
DE50112380D1 (de) Drehratensensor und drehratensensorsystem
DK1331972T3 (da) Farmaceutiske præparater
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60120608D1 (de) Behälteranordnung und Behälter
PT1280522E (pt) Combinacao de eteres carboxialquilicos com anti-hipertensores e a utilizacao farmaceutica